{"qas": [{"question": "What drugs are the least expensive to develop?", "id": "571ae71a32177014007e9fc6", "answers": [{"text": "those based on re-formulation of an existing active ingredient", "answer_start": 694}], "is_impossible": false}, {"question": "What accounts for nearly half of the costs to develop drugs?", "id": "571ae71a32177014007e9fc7", "answers": [{"text": "opportunity cost of investing capital", "answer_start": 51}], "is_impossible": false}, {"question": "What is the consequence in the value chain?", "id": "571ae71a32177014007e9fc8", "answers": [{"text": "increasingly outsource risks related to fundamental research", "answer_start": 435}], "is_impossible": false}, {"question": "What happens when companies outsource?", "id": "571ae71a32177014007e9fc9", "answers": [{"text": "somewhat reshapes the industry ecosystem with biotechnology companies", "answer_start": 503}], "is_impossible": false}, {"question": "What is re-formulations of active ingredients referred to?", "id": "571ae71a32177014007e9fca", "answers": [{"text": "Line-extensions", "answer_start": 778}], "is_impossible": false}, {"question": "Investing capital can increase drug development costs by how much?", "id": "571d1d495efbb31900334ea8", "answers": [{"text": "nearly half the total expense", "answer_start": 284}], "is_impossible": false}, {"question": "What kind of companies have had a more important role in drug development?", "id": "571d1d495efbb31900334ea9", "answers": [{"text": "biotechnology", "answer_start": 549}], "is_impossible": false}, {"question": "What firms tend to outsource drug development?", "id": "571d1d495efbb31900334eaa", "answers": [{"text": "major pharmaceutical multinationals", "answer_start": 391}], "is_impossible": false}, {"plausible_answers": [{"text": "those based on re-formulation of an existing active ingredient", "answer_start": 694}], "question": "What drugs are the least fundamental to develop?", "id": "5ad399f2604f3c001a3fe843", "answers": [], "is_impossible": true}, {"plausible_answers": [{"text": "opportunity cost of investing capital", "answer_start": 51}], "question": "What accounts for nearly half of the costs to develop companies?", "id": "5ad399f2604f3c001a3fe844", "answers": [], "is_impossible": true}, {"plausible_answers": [{"text": "increasingly outsource risks related to fundamental research", "answer_start": 435}], "question": "What is the consequence in the research chain?", "id": "5ad399f2604f3c001a3fe845", "answers": [], "is_impossible": true}, {"plausible_answers": [{"text": "somewhat reshapes the industry ecosystem with biotechnology companies", "answer_start": 503}], "question": "What happens when companies approve drugs?", "id": "5ad399f2604f3c001a3fe846", "answers": [], "is_impossible": true}, {"plausible_answers": [{"text": "Line-extensions", "answer_start": 778}], "question": "What is re-formulations of approved drugs referred to?", "id": "5ad399f2604f3c001a3fe847", "answers": [], "is_impossible": true}], "context": "M\u1ed9t s\u1ed1 \u01b0\u1edbc t\u00ednh n\u00e0y c\u0169ng t\u00ednh \u0111\u1ebfn <a1_0><b9_0> chi ph\u00ed c\u01a1 h\u1ed9i c\u1ee7a v\u1ed1n \u0111\u1ea7u t\u01b0 <b9_0/><a1_0/> nhi\u1ec1u n\u0103m tr\u01b0\u1edbc khi doanh thu \u0111\u01b0\u1ee3c th\u1ef1c hi\u1ec7n (xem gi\u00e1 tr\u1ecb th\u1eddi gian c\u1ee7a ti\u1ec1n). Do r\u1ea5t c\u1ea7n th\u1eddi gian \u0111\u1ec3 kh\u00e1m ph\u00e1, ph\u00e1t tri\u1ec3n v\u00e0 ph\u00ea duy\u1ec7t d\u01b0\u1ee3c ph\u1ea9m, nh\u1eefng chi ph\u00ed n\u00e0y c\u00f3 th\u1ec3 t\u00edch l\u0169y <a5_0> g\u1ea7n m\u1ed9t n\u1eeda t\u1ed5ng chi ph\u00ed <a5_0/> . M\u1ed9t h\u1ec7 qu\u1ea3 tr\u1ef1c ti\u1ebfp trong chu\u1ed7i gi\u00e1 tr\u1ecb ng\u00e0nh d\u01b0\u1ee3c ph\u1ea9m l\u00e0 <a7_0> c\u00e1c c\u00f4ng ty \u0111a qu\u1ed1c gia d\u01b0\u1ee3c ph\u1ea9m l\u1edbn <a7_0/> c\u00f3 khuynh h\u01b0\u1edbng <a2_0><b10_0> ng\u00e0y c\u00e0ng gia t\u0103ng r\u1ee7i ro li\u00ean quan \u0111\u1ebfn nghi\u00ean c\u1ee9u c\u01a1 b\u1ea3n <b10_0/><a2_0/> , c\u00e1i n\u00e0o <a3_0><b11_0> ph\u1ea7n n\u00e0o \u0111\u1ecbnh h\u00ecnh l\u1ea1i h\u1ec7 sinh th\u00e1i ng\u00e0nh v\u1edbi <a6_0> c\u00f4ng ngh\u1ec7 sinh h\u1ecdc <a6_0/> c\u00e1c c\u00f4ng ty <b11_0/><a3_0/> \u0111\u00f3ng vai tr\u00f2 ng\u00e0y c\u00e0ng quan tr\u1ecdng v\u00e0 c\u00e1c chi\u1ebfn l\u01b0\u1ee3c t\u1ed5ng th\u1ec3 \u0111\u01b0\u1ee3c x\u00e1c \u0111\u1ecbnh l\u1ea1i t\u01b0\u01a1ng \u1ee9ng. M\u1ed9t s\u1ed1 lo\u1ea1i thu\u1ed1c \u0111\u01b0\u1ee3c ch\u1ea5p thu\u1eadn, ch\u1eb3ng h\u1ea1n nh\u01b0 <a0_0><b8_0> d\u1ef1a tr\u00ean vi\u1ec7c x\u00e2y d\u1ef1ng l\u1ea1i th\u00e0nh ph\u1ea7n ho\u1ea1t t\u00ednh hi\u1ec7n c\u00f3 <b8_0/><a0_0/> (C\u00f2n \u0111\u01b0\u1ee3c g\u1ecdi l\u00e0 <a4_0><b12_0> Tuy\u1ebfn m\u1edf r\u1ed9ng <b12_0/><a4_0/> ) \u00edt t\u1ed1n k\u00e9m h\u01a1n \u0111\u1ec3 ph\u00e1t tri\u1ec3n."}